Current Ratio of Gain Therapeutics, Inc. from 30 Sep 2021 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Gain Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 30 Sep 2021 to 30 Sep 2025.
  • Gain Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 233%, a 23% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Gain Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 233% -71% -23% 30 Sep 2025
Q2 2025 245% -41% -14% 30 Jun 2025
Q1 2025 274% -18% -6% 31 Mar 2025
Q4 2024 288% -27% -8.6% 31 Dec 2024
Q3 2024 303% -41% -12% 30 Sep 2024
Q2 2024 285% -142% -33% 30 Jun 2024
Q1 2024 292% -240% -45% 31 Mar 2024
Q4 2023 315% -354% -53% 31 Dec 2023
Q3 2023 344% -513% -60% 30 Sep 2023
Q2 2023 427% -601% -58% 30 Jun 2023
Q1 2023 532% -718% -57% 31 Mar 2023
Q4 2022 669% -898% -57% 31 Dec 2022
Q3 2022 857% -502% -37% 30 Sep 2022
Q2 2022 1029% 30 Jun 2022
Q1 2022 1250% 31 Mar 2022
Q4 2021 1568% 31 Dec 2021
Q3 2021 1359% 30 Sep 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.